8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The fate of desmin and titin during the degeneration and regeneration of the soleus muscle of the rat.

      1 , ,
      Acta neuropathologica

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We studied the fate of desmin and titin in rat skeletal muscle during a cycle of degeneration and regeneration induced in vivo by the inoculation of a snake venom. Cryosections of muscle were labelled using antibodies to the two proteins, and examined at fixed time points after venom injection. Early pathological changes in the muscle, such as hypercontraction, preceded the loss of desmin. Immunolabelling using anti-desmin antibodies showed that desmin bridges were still intact when adjacent myofibrils were no longer aligned. The results suggested that although the hydrolysis of desmin is not necessary for the hypercontraction of muscle fibres, it probably contributes to complete fibre breakdown. Titin, or at least the part which lies close to the M-line, remained intact longer than desmin, but was also hydrolysed prior to complete disintegration of the fibres. Both desmin and titin were re-expressed in the regenerating myotubes by 2 days after venom inoculation, and became well organised even before the myofibrils became aligned. We conclude that desmin and titin are involved in both establishing and maintaining the structural integrity of the muscle fibres.

          Related collections

          Author and article information

          Journal
          Acta Neuropathol.
          Acta neuropathologica
          0001-6322
          0001-6322
          1992
          : 84
          : 3
          Affiliations
          [1 ] Muscular Dystrophy Group Research Laboratories, Newcastle General Hospital, Newcastle-upon-Tyne, UK.
          Article
          1384267
          1626efd9-6024-42a7-93c7-22da87b3ce33
          History

          Comments

          Comment on this article